Company profile: ZetaGen Therapeutics
1.1 - Company Overview
Company description
- Provider of small molecule-based osteoinductive therapies and biologics, commercializing an osteoinductive platform. Products include ZetaMet to resolve bone lesions, inhibit pain, and regenerate bone in metastatic bone cancer; ZetaMet-P for metastatic prostate cancer bone lesions; ZetaMAST for unresectable, multifocal breast cancer metastases; ZetaFuse for spinal fusion; ZetaSet for fractures; and ZetaBase bone void filler and graft extender.
Products and services
- ZetaMet™ (Zeta-BC-003): Synthetic, small-molecule therapy engineered to resolve bone lesions, inhibit pain, and regenerate bone, potentially increasing survival in metastatic bone cancer patients
- ZetaFuse™: Synthetic, small-molecule, osteo-inductive biologic architected to aid bone healing in spinal fusions, granted Breakthrough Device Designation for the complete spinal column
- ZetaSet™: Synthetic, osteo-inductive biologic designed to treat osteoporotic fractures, high-energy injuries with bone defects, and fractures of the tibial plateau and plafond
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ZetaGen Therapeutics
Woven Orthopedics
HQ: United States
Website
- Description: Provider of fabric technologies for the neuro-musculoskeletal industry, including the Ogmend Implant Enhancement System, an implantable sleeve designed to secure stable screw fixation in complex scenarios, reduce focal stresses, facilitate bone ingrowth, and increase surface area contact for improved purchase.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Woven Orthopedics company profile →
Gramedica
HQ: United States
Website
- Description: Provider of foot and ankle instability correction solutions, located in Macomb.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gramedica company profile →
Bespoke Innovations
HQ: United States
Website
- Description: Provider of customized prosthetics and prosthetic limb solutions, including Bespoke Fairings, custom coverings for prosthetic legs that recreate the body's form using 3D scanning and allow personalization with various materials and designs, enabled by the Scan.Design.Print 3D process for scanning, design customization, and 3D printing. Incorporated in 2009 and based in San Francisco, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bespoke Innovations company profile →
Corin
HQ: United Kingdom
Website
- Description: Provider of European orthopaedic solutions, offering knee and hip replacement systems and digital surgical tools: Unity Knee total replacement system; TriFit Hip Replacement Platform; OMNIBotics robotic-assisted knee surgery system; Trinity Acetabular hip implant system; and OPSInsight and OPSReView platforms for surgical planning and recurrent dislocation cases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corin company profile →
X-Spine
HQ: United States
Website
- Description: Provider of spinal implants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Spine company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ZetaGen Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ZetaGen Therapeutics
2.2 - Growth funds investing in similar companies to ZetaGen Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ZetaGen Therapeutics
4.2 - Public trading comparable groups for ZetaGen Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →